Korea's first homegrown Covid-19 jab draws experts' approval recommendation
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The vaccine codenamed GBP510 is ready for rollout with independent technology for all production value streams from raw materials to filling and packaging.
Approval of the vaccine candidate also known as SKYCovione was recommended during a meeting of the ministry’s Central Pharmaceutical Review Committee held on Sunday based on safety and efficacy data from all three phases of its clinical trial.
SKYCovione’s recommended dosage is two doses given four weeks apart. This recombinant-protein vaccine jointly developed with the Institute for Protein Design at the University of Washington can be stored at 2 to 8 Celsius degrees unlike mRNA vaccines that require very low temperature storage.
In a Phase 3 clinical trial in some 4,000 adults in six countries, including South Korea, SKYCovione demonstrated superiority to AstraZeneca’s comparator vaccine in terms of immunogenicity and seroconversion. The safety profile was comparable to that of AstraZeneca’s with expected adverse reactions such as fatigue, muscle pain, headache, chills, fever, joint pain, nausea/vomiting, and diarrhea. The expert panel recommended a regulatory follow-up on those side effects after marketing approval.
The ministry said it will soon decide whether to approve the vaccine candidate based on the panel’s opinions.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Korean celebrities in favor by luxury fashion houses as their global faces - Pulse by Maeil Business News Korea
- World’s most expensive drug Zolgensma may soon get reimbursement approval in Korea - Pulse by Maeil Business News Korea
- Korean battery makers look over shoulder as Chinese, Japanese rivals advance in tech - Pulse by Maeil Business News Korea
- Kosdaq rushing with spinoff of promising business ends up losing investors - Pulse by Maeil Business News Korea
- EcoPro Bm shares fly on seemingly depreciated price upon ex-rights and increases in issues - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 금융당국이 손보려는 농협중앙회...NH농협금융 지배구조 ‘복마전’ 왜?
- 대만 치어리더 한국스포츠 첫 진출…K리그 수원FC - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이